B.Riley cuts AXT stock price target on China export risks

B.Riley reduced its price target for AXT, Inc. (NASDAQ:AXTI) to $43.00 from $56.00, citing risks from U.S.-China tech tensions. The company's stock has fallen 69% in six months but gained 275% over a year. AXT reported Q3 revenue of $73.4M, up 162% YoY, with strong earnings. B.Riley warns of potential fragility in export permits and competition from non-Chinese suppliers.

Original reporting
Published Nov 17, 2026, 10:42 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 10:53 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$AXTI
Bearish
high confidence
Mentioned
$AXTI
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$AXTIBearishMed
01

Why it matters

The key trading takeaway is a valuation and risk re-rating from a major analyst, anchored to export-permit fragility and potential customer shifts toward non-Chinese suppliers.

02

Market read

A sell-side target reduction tied to export-permit risk can influence positioning in AXT and related semiconductor-material supply-chain trades.

03

What to watch

The article notes permit improvement after February 2025 export-control changes; if that improvement persists, the market may over-discount the worst-case Washington-Beijing retaliation scenario.

Relevance 6/10Novelty 5/10Timing: today, as the analyst price-target cut can drive same-day sentiment and positioning

Background

AXT manufactures indium phosphide substrates in China and needs Beijing export permits for shipments abroad; B.Riley links the valuation to the durability of permit availability.

Company-level read

Ticker impact

$AXTIBearishHigh confidence
Context

B.Riley cut AXT’s price target to $43 from $56, citing AXT’s China export-permit dependence for indium phosphide substrates.

Expected impact

Likely near-term pressure as the market reprices risk around export permits and customer qualification of non-Chinese suppliers.

Evidence & confidence

The article centers on a fresh sell-side target reduction tied to a specific operational bottleneck (China export permits) and a scenario where Washington tightens and Beijing slows permits again.

Market effects

Highlights supply-chain and export-control risk for photonics/semiconductor materials tied to China-controlled inputs, which can pressure sentiment across adjacent substrate and component names.

US-listed semiconductor supply-chain equities may see correlated risk-off moves on renewed export-permit uncertainty.

Reinforces that US-China technology tensions can directly affect cross-border shipments of critical semiconductor materials, impacting global AI supply chains.

Counterpoint

Despite the target cut, the company reported record Q3 revenue and a large backlog, suggesting demand strength may offset some permit risk if guidance holds.

Key entities

  • AXT, Inc.

    NASDAQ-listed indium phosphide substrate maker whose shipments depend on China export permits.

  • B.Riley

    Cut AXT’s price target to $43 from $56 while keeping a Neutral rating.

  • Lumentum

    Named as a customer that could qualify non-Chinese suppliers if export permits tighten.

  • Coherent

    Named as a customer that could qualify non-Chinese suppliers if export permits tighten.

  • Freiberger

    Germany-based non-Chinese supplier mentioned as a potential alternative.

Related articles

$AXTIMedAI 8/10

AXT (AXTI) Q3 2026 Earnings Call Transcript

AXT (AXTI) reported Q3 2026 revenue of $73.4M, up 54% QoQ and 162% YoY. Gross margin increased to 56.1% non-GAAP. Net profit was $26.8M non-GAAP. The company signed a long-term supply agreement with Lumentum, receiving a $43.5M prepayment. AXT's subsidiary, Tongmei, secured $545M private equity financing for capacity expansion. AXT expects continued growth in indium phosphide demand, driven by AI data center needs.

$AXTIMedAI 8/10

What AXT (AXTI) Said on Its Q3 Earnings Call

AXT reported Q3 non-GAAP net income of $26.8M ($0.41 per share), up from $11.9M ($0.19 per share) in Q2. The company signed a $43.5M prepayment agreement with Lumentum and saw its indium phosphide backlog exceed $500M. AXT plans to double its capacity by 2027 and expects Q4 non-GAAP earnings of $0.57-$0.59 per share.

$AXTIMedAI 8/10

AXT: Q3 Earnings Snapshot

AXT Inc. (AXTI) reported Q3 net income of $25.7M, or 39 cents per share, beating analyst estimates. Revenue was $73.4M, also exceeding forecasts. Shares have tripled since January, closing at $60.88 on Thursday.

$AXTIMed

AXT, Inc. Announces Third Quarter 2026 Financial Results

AXT INC (AXTI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 AXT, Inc. Third Quarter 2026 Results October 29, 2026 Page 1 of 6 AXT, Inc. Announces Third Quarter 2026 Financial Results FREMONT, Calif., October 29, 2026 – AXT, Inc. (NasdaqGS: AXTI), a leading manufacturer of compound semiconductor wafer substrates, today reporte